These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28546700)

  • 1. Advanced Primary Epithelial Ovarian and Peritoneal Carcinoma-Does Diagnostic Accuracy of Preoperative CT Scan for Detection of Peritoneal Metastatic Sites Reflect into Prediction of Suboptimal Debulking? A Prospective Study.
    Bagul K; Vijaykumar DK; Rajanbabu A; Antony MA; Ranganathan V
    Indian J Surg Oncol; 2017 Jun; 8(2):98-104. PubMed ID: 28546700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
    Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Mironov S; Iyer RB; Zhou Q; Iasonos A; Paul H; Hosaka M; Aghajanian CA; Leitao MM; Gardner GJ; Abu-Rustum NR; Sonoda Y; Levine DA; Hricak H; Chi DS
    Gynecol Oncol; 2014 Sep; 134(3):455-61. PubMed ID: 25019568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer.
    Borley J; Wilhelm-Benartzi C; Yazbek J; Williamson R; Bharwani N; Stewart V; Carson I; Hird E; McIndoe A; Farthing A; Blagden S; Ghaem-Maghami S
    BJOG; 2015 May; 122(6):843-849. PubMed ID: 25132394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
    Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
    Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
    Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
    Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic flow-chart to identify bowel involvement in patients with stage IIIC-IV ovarian cancer: Can laparoscopy improve the accuracy of CT scan?
    Tozzi R; Traill Z; Campanile RG; Kilic Y; Baysal A; Giannice R; Morotti M; Soleymani Majd H; Valenti G
    Gynecol Oncol; 2019 Nov; 155(2):207-212. PubMed ID: 31481247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.
    Ferrandina G; Sallustio G; Fagotti A; Vizzielli G; Paglia A; Cucci E; Margariti A; Aquilani L; Garganese G; Scambia G
    Br J Cancer; 2009 Oct; 101(7):1066-73. PubMed ID: 19738608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prediction Model for Optimal Primary Debulking Surgery Based on Preoperative Computed Tomography Scans and Clinical Factors in Patients With Advanced Ovarian Cancer: A Multicenter Retrospective Cohort Study.
    Gu Y; Qin M; Jin Y; Zuo J; Li N; Bian C; Zhang Y; Li R; Wu YM; Wang CY; Zhang KQ; Yue Y; Wu LY; Pan LY
    Front Oncol; 2020; 10():611617. PubMed ID: 33489921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.
    Qayyum A; Coakley FV; Westphalen AC; Hricak H; Okuno WT; Powell B
    Gynecol Oncol; 2005 Feb; 96(2):301-6. PubMed ID: 15661212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study on the diagnostic pathway of patients with stage IIIC-IV ovarian cancer: Exploratory laparoscopy (EXL) + CT scan VS. CT scan.
    Tozzi R; Traill Z; Valenti G; Ferrari F; Gubbala K; Campanile RG
    Gynecol Oncol; 2021 Apr; 161(1):188-193. PubMed ID: 33514484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of clinicopathologic factors as indicators for early prediction of suboptimal debulking surgery after neoadjuvant chemotherapy in advanced ovarian cancer.
    Son JH; Chang K; Kong TW; Paek J; Chang SJ; Ryu HS
    J Obstet Gynaecol Res; 2018 Jul; 44(7):1294-1301. PubMed ID: 29683235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
    Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
    Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Stashwick C; Post MD; Arruda JS; Spillman MA; Behbakht K; Davidson SA; Kelly MG
    Int J Gynecol Cancer; 2011 Nov; 21(8):1422-7. PubMed ID: 21997170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer.
    Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Iyer RB; Zhou Q; Iasonos A; Denesopolis J; Zivanovic O; Long Roche KC; Sonoda Y; Coleman RL; Abu-Rustum NR; Hricak H; Chi DS
    Gynecol Oncol; 2017 Apr; 145(1):27-31. PubMed ID: 28209497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
    Nelson BE; Rosenfield AT; Schwartz PE
    J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
    Dowdy SC; Mullany SA; Brandt KR; Huppert BJ; Cliby WA
    Cancer; 2004 Jul; 101(2):346-52. PubMed ID: 15241833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective comparison of integrated FDG-PET/contrast-enhanced CT and contrast-enhanced CT for pretreatment imaging of advanced epithelial ovarian cancer.
    Hynninen J; Kemppainen J; Lavonius M; Virtanen J; Matomäki J; Oksa S; Carpén O; Grénman S; Seppänen M; Auranen A
    Gynecol Oncol; 2013 Nov; 131(2):389-94. PubMed ID: 23994535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT scan does not predict optimal debulking in stage III-IV epithelial ovarian cancer: a multicentre validation study.
    MacKintosh ML; Rahim R; Rajashanker B; Swindell R; Kirmani BH; Hunt J; Brockbank E; Barton DP; Clayton RD
    J Obstet Gynaecol; 2014 Jul; 34(5):424-8. PubMed ID: 24725017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a prediction model for residual disease in newly diagnosed advanced ovarian cancer.
    Janco JM; Glaser G; Kim B; McGree ME; Weaver AL; Cliby WA; Dowdy SC; Bakkum-Gamez JN
    Gynecol Oncol; 2015 Jul; 138(1):70-7. PubMed ID: 25913130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.